ACHV Achieve Life Sciences, Inc. - Common Shares
$7,53
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 11, 2026
52W-Spanne
$3–$8
99% of range
Analystenbewertung
BUY
15 analysts
Kursziel
$14
+84% upside
P/E (TTM)
-4.0
ROE
—
Nettogewinnmarge
—
ACHV Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$7.53
Marktkapitalisierung
—
P/E (TTM)
-4.0
EPS (TTM)
$-1.25
Umsatz (TTM)
—
Dividendenrendite
—
ROE
—
Verschuldungsgrad
—
52W-Spanne
$3 – $8
ACHV Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
2018-12-31
→
2019-12-31
EPS
$-1.25
2020-12-31
→
2025-12-31
Freier Cashflow
—
2016-12-31
→
2023-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ACHV
Peer-Median
P/E (TTM)
-4.0
134.0
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ACHV
Peer-Median
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ACHV
Peer-Median
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ACHV
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ACHV
Peer-Median
ACHV Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
15 Analysten
- Starker Kauf 3 20,0%
- Kauf 11 73,3%
- Halten 1 6,7%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
12 Analysten · 2026-08-16
Median
$12.50
Mittelwert
$13.83
← Unter allen Zielen
$7.53
Tief
$9.00
Hoch
$21.00
Median-Ziel
$12.50
+66,0%
Mittelwert-Ziel
$13.83
+83,7%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.19 | $-0.31 | 0.12% |
| 31. Dezember 2025 | $-0.28 | $-0.28 | -0.00% |
| 30. September 2025 | $-0.28 | $-0.26 | -0.02% |
| 30. Juni 2025 | $-0.37 | $-0.37 | 0.00% |
| 31. März 2025 | $-0.37 | $-0.37 | 0.00% |
| 31. Dezember 2024 | $-0.36 | $-0.33 | -0.03% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ACHV | — | -4.0 | — | — | — | — |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | — |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | — |
| MNPR | — | — | — | — | — | — |
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | — |
| CTMX | $725M | — | -44.8% | -22.8% | -15.9% | — |
| NGNE | $319M | -4.9 | — | — | -33.6% | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | — |
| BBOT | $1.00B | -2.9 | — | — | -146.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | |
| R&D Expense | · | $23M | $16M | $30M | $24M | $7M | $10M | $6M | |
| SG&A Expense | · | $16M | $11M | $11M | $9M | $8M | $7M | $7M | |
| Operating Expenses | $55M | $39M | $27M | $41M | $33M | $15M | $17M | $13M | |
| Interest Expense | · | · | $3M | $2M | · | · | · | · | |
| Interest Income | $1M | $2M | $825.0K | $199.0K | $17.0K | $69.0K | $170.0K | $171.0K | |
| Other Non-op | $-36.0K | $-30.0K | $-9.0K | $40.0K | $-75.0K | $-49.0K | $-37.0K | $-45.0K | |
| Pretax Income | $-55M | $-40M | $-30M | $-42M | $-33M | $-15M | $-16M | $-13M | |
| Net Income | $-55M | $-40M | $-30M | $-42M | $-33M | $-15M | $-16M | $-13M | |
| EPS (Basic) | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 | $-5.42 | · | · | |
| EPS (Diluted) | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 | $-5.42 | · | · | |
| Shares (Basic) | 43,594,652 | 32,071,146 | 19,827,534 | 10,593,034 | 8,119,836 | 2,718,909 | · | · | |
| Shares (Diluted) | 43,594,652 | 32,071,146 | 19,827,534 | 10,593,034 | 8,119,836 | 2,718,909 | · | · |
Bilanz 22
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $13M | $16M | $25M | $43M | $36M | $17M | $10M | |
| Short-term Investments | $15M | $22M | · | · | · | · | · | $5M | |
| Receivables | · | · | · | · | · | · | $8.0K | $7.0K | |
| Prepaid Expense | · | $2M | $1M | $2M | $1M | $1M | $670.0K | $926.0K | |
| Current Assets | $40M | $36M | $17M | $27M | $45M | $37M | $17M | $16M | |
| PP&E (Net) | $3.0K | $8.0K | $13.0K | $4.0K | $15.0K | $42.0K | $57.0K | $35.0K | |
| PP&E (Gross) | $256.0K | $256.0K | $256.0K | $303.0K | $302.0K | $674.0K | $657.0K | $755.0K | |
| Accum. Depreciation | $253.0K | $248.0K | $243.0K | $299.0K | $287.0K | $632.0K | $600.0K | $720.0K | |
| Goodwill | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Intangibles | $751.0K | $974.0K | $1M | $1M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | · | · | · | $187.0K | $187.0K | $118.0K | |
| Total Assets | $42M | $39M | $19M | $30M | $48M | $40M | $21M | $19M | |
| Accounts Payable | · | $2M | $618.0K | $2M | $841.0K | $332.0K | $859.0K | $144.0K | |
| Current Liabilities | $9M | $7M | $21M | $22M | $5M | $3M | $3M | $3M | |
| Capital Leases | $5.0K | $66.0K | $6.0K | $69.0K | $4.0K | $77.0K | $159.0K | $12.0K | |
| Total Liabilities | $20M | $18M | $21M | $22M | $19M | $3M | $3M | $3M | |
| Common Stock | $121.0K | $103.0K | $90.0K | $87.0K | $79.0K | $76.0K | $41.0K | $18.0K | |
| Retained Earnings | $-260M | $-206M | $-166M | $-136M | $-94M | $-60M | $-46M | $-25M | |
| AOCI | $10.0K | $31.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Stockholders' Equity | $22M | $21M | $-1M | $8M | $28M | $37M | $18M | $16M | |
| Liabilities + Equity | $42M | $39M | $19M | $30M | $48M | $40M | $21M | $19M | |
| Shares Outstanding | 53,233,988 | 34,685,072 | 21,165,760 | 17,897,029 | 9,453,542 | 6,111,735 | 1,474,258 | 6,721,117 |
Cashflow 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $228.0K | $229.0K | $228.0K | $236.0K | $250.0K | $255.0K | · | · | |
| Stock-based Comp | $9M | $5M | $3M | $3M | $2M | $1M | $1M | $854.0K | |
| Amort. of Intangibles | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | |
| Operating Cash Flow | $-49M | $-30M | $-24M | $-38M | $-29M | $-13M | $-15M | $-11M | |
| CapEx | $3.0K | · | $21.0K | · | · | $17.0K | $53.0K | $46.0K | |
| Investing Cash Flow | $6M | $-22M | $-21.0K | · | · | $-17.0K | $5M | $-5M | |
| Financing Cash Flow | $52M | $49M | $15M | $19M | $37M | $33M | $17M | $20M | |
| Net Change in Cash | $8M | $-3M | $-9M | $-18M | $7M | $19M | $7M | $4M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | · | · | $-24M | · | · | $-13M | $-15M | $-11M |
Rentabilität 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -137.3% | -120.8% | · | -75.5% | -48.0% | -81.6% | -87.6% | |
| ROE | · | -152.4% | -2302.3% | · | -105.7% | -46.8% | -125.2% | -84.7% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 5.5 | 0.8 | · | 9.8 | 12.6 | 6.0 | 4.8 | |
| Quick Ratio | · | 5.1 | 0.7 | · | 9.5 | 12.2 | 5.8 | 4.5 |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 0.0 | 0.0 |
Bewertung (TTM) 9
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | $0 | $0 | |
| Net Income TTM | $-55M | $-40M | $-30M | $-42M | $-33M | $-15M | $-16M | $-13M | |
| Market Cap | · | $122M | $87M | · | $74M | $50M | $313M | $163M | |
| P/E | -4.0 | -2.8 | -2.7 | -0.6 | -1.9 | -1.5 | · | · | |
| P/B | · | 5.8 | -60.2 | · | 2.6 | 1.3 | 17.3 | 10.3 | |
| P / Tangible Book | 13.4 | 6.5 | · | 7.5 | 2.9 | 1.4 | · | · | |
| P / Cash Flow | · | -4.1 | -3.6 | · | -2.5 | -3.7 | -20.5 | -15.3 | |
| P / FCF | · | · | -3.6 | · | · | -3.7 | -20.5 | -15.2 | |
| Earnings Yield | -25.1% | -35.2% | -36.4% | -163.3% | -52.4% | -66.9% | · | · |
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | $5M | $7M | $7M | · | $8M | $5M | $3M | $4M | $5M | $6M | $10M | $7M | $4M | |
| SG&A Expense | · | · | · | $9M | $6M | $6M | · | $5M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $18M | $10M | $15M | $15M | $13M | $13M | $12M | $12M | $8M | $6M | $7M | $8M | $9M | $13M | $10M | $7M | |
| Interest Expense | · | · | · | · | · | · | · | $366.0K | $804.0K | $813.0K | $781.0K | $712.0K | $573.0K | $481.0K | $404.0K | $357.0K | |
| Interest Income | $1M | $297.0K | $427.0K | $554.0K | $192.0K | $322.0K | $482.0K | $673.0K | $833.0K | $368.0K | $262.0K | $193.0K | $162.0K | $73.0K | $4.0K | $4.0K | |
| Other Non-op | $-5.0K | $-13.0K | $7.0K | $-5.0K | $-59.0K | $21.0K | $-5.0K | $-8.0K | $-2.0K | $-15.0K | $-17.0K | $-6.0K | $-3.0K | $-30.0K | $5.0K | $6.0K | |
| Net Income | $-75M | $-10M | $-15M | $-14M | $-13M | $-13M | $-12M | $-13M | $-8M | $-6M | $-7M | $-8M | $-9M | $-13M | $-10M | $-8M | |
| EPS (Basic) | $-0.80 | $-0.19 | $-0.23 | $-0.28 | $-0.37 | $-0.37 | $-0.37 | $-0.36 | $-0.25 | $-0.26 | $-0.34 | $-0.43 | $-0.50 | $-1.35 | $-1.08 | $-0.80 | |
| EPS (Diluted) | $-0.80 | $-0.19 | $-0.23 | $-0.28 | $-0.37 | $-0.37 | $-0.37 | $-0.36 | $-0.25 | $-0.26 | $-0.34 | $-0.43 | $-0.50 | $-1.35 | $-1.08 | $-0.80 | |
| Shares (Basic) | 93,510,544 | 53,381,989 | -76,793,154 | 51,017,662 | 34,685,072 | 34,685,072 | -61,650,747 | 34,355,050 | 34,318,709 | 25,048,134 | 21,127,281 | 19,048,627 | 17,917,769 | 9,693,788 | 9,647,726 | 9,458,745 | |
| Shares (Diluted) | 93,510,544 | 53,381,989 | -76,793,154 | 51,017,662 | 34,685,072 | 34,685,072 | -61,650,747 | 34,355,050 | 34,318,709 | 25,048,134 | 21,127,281 | 19,048,627 | 17,917,769 | 9,693,788 | 9,647,726 | 9,458,745 |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $28M | $21M | $32M | $52M | $13M | $13M | $10M | $15M | $66M | $20M | $25M | $17M | $18M | $29M | $36M | |
| Short-term Investments | $139M | $1M | $15M | $16M | $4M | $10M | $22M | $33M | $47M | · | · | · | · | · | · | · | |
| Prepaid Expense | · | · | · | $2M | $2M | $2M | · | $3M | $1M | $1M | $2M | $958.0K | $2M | $3M | $1M | $1M | |
| Current Assets | $188M | $31M | $40M | $50M | $57M | $25M | $36M | $46M | $63M | $68M | $22M | $26M | $18M | $21M | $31M | $38M | |
| PP&E (Net) | · | · | $3.0K | · | · | · | $8.0K | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | $256.0K | · | · | · | $256.0K | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $253.0K | · | · | · | $248.0K | · | · | · | · | · | · | · | · | · | |
| Goodwill | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Intangibles | $640.0K | $696.0K | $751.0K | $807.0K | $863.0K | $918.0K | $974.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | |
| Total Assets | $190M | $33M | $42M | $52M | $59M | $27M | $39M | $48M | $65M | $70M | $24M | $29M | $21M | $24M | $34M | $41M | |
| Accounts Payable | · | · | · | $2M | $1M | $2M | · | $1M | $550.0K | $373.0K | $638.0K | $361.0K | $1M | $412.0K | $656.0K | $418.0K | |
| Accrued Liabilities | $200.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $198M | $12M | $9M | $10M | $9M | $7M | $7M | $7M | $14M | $21M | $4M | $3M | $20M | $7M | $5M | $4M | |
| Capital Leases | · | · | $5.0K | $21.0K | $37.0K | $52.0K | $66.0K | · | · | · | $22.0K | $38.0K | $54.0K | · | · | · | |
| Total Liabilities | $205M | $22M | $20M | $18M | $17M | $17M | $18M | $17M | $23M | $21M | $20M | $19M | $20M | $23M | $21M | $19M | |
| Common Stock | $170.0K | $121.0K | $121.0K | $121.0K | $118.0K | $103.0K | $103.0K | $103.0K | $103.0K | $103.0K | $90.0K | $90.0K | $87.0K | $79.0K | $79.0K | $79.0K | |
| Retained Earnings | $-345M | $-270M | $-260M | $-246M | $-231M | $-218M | $-206M | $-193M | $-181M | $-172M | $-160M | $-153M | $-145M | $-125M | $-112M | $-101M | |
| AOCI | $-88.0K | $2.0K | $10.0K | $9.0K | $3.0K | $6.0K | $31.0K | $75.0K | $-7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Stockholders' Equity | $-15M | $11M | $22M | $34M | $42M | $10M | $21M | $31M | $42M | $49M | $4M | $10M | $443.0K | $1M | $13M | $21M | |
| Liabilities + Equity | $190M | $33M | $42M | $52M | $59M | $27M | $39M | $48M | $65M | $70M | $24M | $29M | $21M | $24M | $34M | $41M | |
| Shares Outstanding | 102,717,200 | 53,240,988 | 53,233,988 | 52,812,488 | 49,685,072 | 34,685,072 | 34,685,072 | 34,389,946 | 34,341,303 | 34,251,911 | 21,165,760 | 21,105,760 | 17,930,362 | 9,710,747 | 9,681,855 | 9,473,577 |
Cashflow 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $58.0K | $57.0K | $57.0K | $54.0K | $55.0K | $62.0K | $58.0K | $57.0K | $57.0K | $57.0K | $58.0K | $55.0K | $58.0K | $55.0K | $56.0K | $60.0K | |
| Stock-based Comp | $7M | $-685.0K | $1M | $2M | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $829.0K | $840.0K | $823.0K | |
| Amort. of Intangibles | · | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | |
| Operating Cash Flow | $-11M | $-7M | $-18M | $-11M | $-9M | $-11M | $-9M | $-10M | $-5M | $-5M | $-5M | $-7M | $-8M | $-11M | $-8M | $-7M | |
| Investing Cash Flow | $-138M | $14M | $709.0K | $-13M | $7M | $11M | $12M | $13M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $168M | $21.0K | $6M | $4M | · | · | $682.0K | $-8M | $-153.0K | $56M | $0 | $15M | $47.0K | $146.0K | $1M | $95.0K | |
| Net Change in Cash | $20M | $7M | $-11M | $-20M | $39M | $263.0K | $3M | $-5M | $-52M | $51M | $-5M | $9M | $-8M | $-11M | $-7M | $-7M |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -60.0% | -33.6% | · | -28.9% | -20.6% | -26.3% | · | -34.6% | -18.1% | -14.3% | -29.6% | -26.2% | -29.3% | -42.5% | -26.3% | -20.4% | |
| ROE | -554.0% | -97.0% | · | -44.4% | -30.3% | -43.0% | · | -70.7% | -32.6% | -26.0% | -279.7% | -72.1% | -82.2% | -73.2% | -38.8% | -29.4% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 2.6 | · | 5.1 | 6.6 | 3.5 | · | 6.8 | 4.6 | 3.3 | 5.4 | 7.7 | 0.9 | 3.0 | 5.8 | 9.4 | |
| Quick Ratio | 0.9 | 2.5 | · | 4.9 | 6.5 | 3.3 | · | 6.4 | 4.5 | 3.2 | 4.9 | 7.3 | 0.8 | 2.6 | 5.5 | 9.1 |
Bewertung (TTM) 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-112M | $-50M | · | $-52M | $-47M | $-40M | · | $-35M | $-30M | $-31M | $-37M | $-41M | $-40M | $-38M | $-32M | $-33M | |
| Market Cap | $671M | $157M | · | $166M | $112M | $93M | · | $163M | $161M | $156M | $91M | $110M | $122M | $32M | $47M | $72M | |
| P/E | -4.0 | -2.4 | · | -2.3 | -1.7 | -2.2 | · | -3.9 | -3.7 | -3.0 | -1.6 | -1.5 | -1.8 | -0.8 | -1.2 | · | |
| P/B | -45.7 | 14.7 | · | 4.9 | 2.7 | 9.0 | · | 5.2 | 3.8 | 3.2 | 22.5 | 11.3 | 275.2 | 30.7 | 3.6 | 3.3 | |
| P / Tangible Book | · | 17.5 | · | 5.2 | 2.8 | 11.1 | · | 5.6 | 4.0 | 3.3 | 51.9 | 14.9 | · | · | 4.5 | 3.8 | |
| P / Cash Flow | · | -22.6 | · | · | · | -8.4 | · | · | · | -29.5 | · | · | -14.7 | · | · | -10.6 | |
| Earnings Yield | -25.1% | -41.2% | · | -43.8% | -59.7% | -46.4% | · | -25.5% | -27.2% | -33.6% | -60.9% | -64.7% | -54.9% | -119.4% | -84.4% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-55M | $-40M | $-30M | $-42M | $-33M |
| Verwässerte EPS | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | — | 5.5 | 0.8 | — | 9.8 |
| Quick Ratio | — | 5.1 | 0.7 | — | 9.5 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | — | — | $-24M | — | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 123 Einreicher · $477.1M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 51 (+34 vs. Vorquartal) | 17 (+8 vs. Vorquartal) | 37 (+16 vs. Vorquartal) | 14 (-8 vs. Vorquartal) | +55.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $49.724.879 | 7.614.836 | 10,42% | Aktien |
| TPG GP A, LLC | $44.910.597 | 6.877.580 | 9,41% | Aktien |
| venBio Partners LLC | $38.623.122 | 5.914.720 | 8,10% | Aktien |
| Logos Global Management LP | $35.425.250 | 5.425.000 | 7,43% | Aktien |
| FRANKLIN RESOURCES INC | $32.344.527 | 4.953.220 | 6,78% | Aktien |
| Paradigm Biocapital Advisors LP | $32.335.620 | 4.951.856 | 6,78% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $27.039.502 | 4.140.812 | 5,67% | Aktien |
| Propel Bio Management, LLC | $26.342.138 | 4.034.018 | 5,52% | Aktien |
| STATE STREET CORP | $19.234.285 | 2.945.526 | 4,03% | Aktien |
| Venrock Adviser, LLC | $17.964.239 | 2.751.032 | 3,77% | Aktien |
| Vivo Capital, LLC | $17.964.239 | 2.751.032 | 3,77% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $14.496.600 | 2.220.000 | 3,04% | Aktien |
| Alyeska Investment Group, L.P. | $12.574.965 | 1.925.722 | 2,64% | Aktien |
| MARSHALL WACE, LLP | $11.778.781 | 1.803.795 | 2,47% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $11.492.229 | 1.759.568 | 2,41% | Aktien |
| Simplify Asset Management Inc. | $9.351.646 | 1.432.105 | 1,96% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $9.090.511 | 1.392.115 | 1,91% | Aktien |
| Caption Management, LLC | $7.676.015 | 1.175.500 | 1,61% | Kaufoption |
| LPL Financial LLC | $5.891.725 | 902.255 | 1,23% | Aktien |
| Spruce Street Capital LP | $4.810.240 | 736.637 | 1,01% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $3.877.194 | 593.751 | 0,81% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.771.075 | 577.500 | 0,79% | Kaufoption |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.510.502 | 537.596 | 0,74% | Aktien |
| KVP Capital Advisors, LP | $3.019.178 | 462.355 | 0,63% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.880.951 | 441.187 | 0,60% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $2.741.340 | 419.807 | 0,57% | Aktien |
| UBS Group AG | $1.837.555 | 281.402 | 0,39% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.515.861 | 232.138 | 0,32% | Aktien |
| Caption Management, LLC | $1.487.096 | 227.733 | 0,31% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1.483.472 | 227.178 | 0,31% | Aktien |
| JANE STREET GROUP, LLC | $1.331.467 | 203.900 | 0,28% | Kaufoption |
| CITADEL ADVISORS LLC | $1.326.243 | 203.100 | 0,28% | Kaufoption |
| RENAISSANCE TECHNOLOGIES LLC | $1.162.660 | 178.049 | 0,24% | Aktien |
| TWO SIGMA ADVISERS, LP | $1.043.203 | 209.900 | 0,22% | Aktien |
| CITADEL ADVISORS LLC | $804.032 | 123.129 | 0,17% | Aktien |
| CANTOR FITZGERALD, L. P. | $794.250 | 121.631 | 0,17% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $791.534 | 121.215 | 0,17% | Aktien |
| BANK OF AMERICA CORP /DE/ | $758.727 | 116.191 | 0,16% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $677.161 | 103.700 | 0,14% | Verkaufsoption |
| WELLS FARGO & COMPANY/MN | $650.564 | 99.627 | 0,14% | Aktien |
| Shay Capital LLC | $606.049 | 92.810 | 0,13% | Aktien |
| XTX Topco Ltd | $587.896 | 90.030 | 0,12% | Aktien |
| RHUMBLINE ADVISERS | $568.253 | 87.023 | 0,12% | Aktien |
| Blue Trust, Inc. | $560.849 | 85.888 | 0,12% | Aktien |
| Diametric Capital, LP | $530.098 | 81.179 | 0,11% | Aktien |
| CITIGROUP INC | $454.632 | 69.622 | 0,10% | Aktien |
| MANCHESTER FINANCIAL INC | $438.666 | 67.177 | 0,09% | Aktien |
| MEMBERS WEALTH LLC | $435.962 | 66.763 | 0,09% | Aktien |
| Virtus Investment Advisers, LLC | $387.066 | 59.275 | 0,08% | Aktien |
| ADAR1 Capital Management, LLC | $351.314 | 53.800 | 0,07% | Aktien |
| JANE STREET GROUP, LLC | $329.197 | 50.413 | 0,07% | Aktien |
| MetLife Investment Management, LLC | $300.282 | 45.985 | 0,06% | Aktien |
| OSAIC HOLDINGS, INC. | $281.540 | 43.115 | 0,06% | Aktien |
| WINTON GROUP Ltd | $277.525 | 42.500 | 0,06% | Aktien |
| GOLDMAN SACHS GROUP INC | $267.573 | 40.976 | 0,06% | Aktien |
| Bank of New York Mellon Corp | $261.559 | 40.055 | 0,05% | Aktien |
| Rafferty Asset Management, LLC | $245.012 | 37.521 | 0,05% | Aktien |
| BlackRock, Inc. | $235.015 | 35.990 | 0,05% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $233.062 | 35.691 | 0,05% | Aktien |
| Next Capital Management LLC | $228.517 | 34.995 | 0,05% | Aktien |
| AMERIFLEX GROUP, INC. | $219.395 | 33.598 | 0,05% | Aktien |
| Vanguard Global Advisers, LLC | $211.624 | 32.408 | 0,04% | Aktien |
| Invesco Ltd. | $202.691 | 31.040 | 0,04% | Aktien |
| JPMORGAN CHASE & CO | $201.042 | 32.270 | 0,04% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $198.329 | 30.372 | 0,04% | Aktien |
| Rockefeller Capital Management L.P. | $195.900 | 30.000 | 0,04% | Aktien |
| Jones Hill Capital LP | $174.743 | 26.760 | 0,04% | Aktien |
| BCV Asset Management Inc. | $164.591 | 26.365 | 0,03% | Aktien |
| AXQ CAPITAL, LP | $164.380 | 25.173 | 0,03% | Aktien |
| Nuveen Asset Management, LLC | $164.271 | 46.668 | 0,03% | Aktien |
| Robertson Stephens Wealth Management, LLC | $163.250 | 25.000 | 0,03% | Aktien |
| Keating Financial Advisory Services, Inc. | $162.669 | 24.911 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $149.916 | 22.958 | 0,03% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $143.884 | 48.940 | 0,03% | Aktien |
| Scientech Research LLC | $143.706 | 22.007 | 0,03% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $134.583 | 20.610 | 0,03% | Aktien |
| SEI INVESTMENTS CO | $133.865 | 20.500 | 0,03% | Aktien |
| Nuveen, LLC | $133.865 | 20.500 | 0,03% | Aktien |
| PROFUND ADVISORS LLC | $129.660 | 19.856 | 0,03% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $125.376 | 19.200 | 0,03% | Aktien |
| nVerses Capital, LLC | $118.852 | 18.201 | 0,02% | Aktien |
| VANGUARD GROUP INC | $112.337 | 22.603 | 0,02% | Aktien |
| Cubist Systematic Strategies, LLC | $111.898 | 35.523 | 0,02% | Aktien |
| MAGNOLIA CAPITAL ADVISORS LLC | $98.603 | 15.100 | 0,02% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $96.931 | 14.844 | 0,02% | Aktien |
| SBI Securities Co., Ltd. | $96.912 | 14.841 | 0,02% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $89.696 | 13.736 | 0,02% | Aktien |
| StoneX Group Inc. | $86.507 | 16.342 | 0,02% | Aktien |
| PRUDENTIAL FINANCIAL INC | $85.151 | 13.040 | 0,02% | Aktien |
| Alpine Global Management, LLC | $81.625 | 12.500 | 0,02% | Aktien |
| NORTHERN TRUST CORP | $79.790 | 12.219 | 0,02% | Aktien |
| Windsor Capital Management, LLC | $70.635 | 10.817 | 0,01% | Aktien |
| BARCLAYS PLC | $66.861 | 10.239 | 0,01% | Aktien |
| ProShare Advisors LLC | $66.554 | 10.192 | 0,01% | Aktien |
| Legal & General Group Plc | $49.334 | 7.555 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $46.128 | 7.064 | 0,01% | Aktien |
| FMR LLC | $41.211 | 6.311 | 0,01% | Aktien |
| Russell Investments Group, Ltd. | $40.642 | 6.224 | 0,01% | Aktien |
| Point72 Asia (Singapore) Pte. Ltd. | $23.641 | 7.505 | 0,00% | Aktien |
| Allworth Financial LP | $19.590 | 3.000 | 0,00% | Aktien |
Unternehmensinsider 48 Insider · 17 Führungskräfte · 26 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Andrew D. Goldberg | CEO and President | 18. April 2026 A | — | 0 | 0 | $0 |
| John Bencich | CEO | 16. August 2024 A | 100.636 | 0 | 0 | $0 |
| Mark K Oki | Chief Financial Officer | 28. Januar 2026 A | 127.940 | 0 | 1 | $-146.175 |
| Michelle Renee Griffin | CFO | 8. Mai 2012 A | — | 0 | 0 | $0 |
| Stephen Charles Anderson | CFO and Secretary | 31. Dezember 2009 A | 10.000 | 0 | 0 | $0 |
| Alan Fuhrman | Senior Vice President & CFO | 18. März 2008 A | — | 0 | 0 | $0 |
| Cindy Jacobs | President & CMO | 4. September 2025 M | 115.585 | 0 | 1 | $-76.532 |
| Mark Lawrence Rubinstein | Chief Medical Officer | 28. Januar 2026 A | — | 0 | 0 | $0 |
| Craig Donnelly | Chief Operations Officer | 28. Januar 2026 A | — | 0 | 0 | $0 |
| Jaime Xinos | Chief Commercial Officer | 28. Januar 2026 A | 74.432 | 0 | 1 | $-57.766 |
| Jerry Wann | Principal Accounting Officer | 28. Januar 2026 A | 32.694 | 0 | 1 | $-38.974 |
| Erik Atkisson | Chief Legal Officer | 4. Dezember 2025 A | — | 0 | 0 | $0 |
| Anthony Clarke | CSO | 28. April 2022 M | 3.502 | 0 | 0 | $0 |
| Susan D. Wyrick | PAO | 14. März 2014 A | 1.312 | 0 | 0 | $0 |
| Cameron William Lawrence | Principal Accounting Officer | 8. Mai 2012 A | 950 | 0 | 0 | $0 |
| Craig Steven Eudy | Principal Accounting Officer | 29. Dezember 2006 A | — | 0 | 0 | $0 |
| Michael B Stewart | Sr. VP & Chief Medical Officer | 16. Dezember 2005 A | — | 0 | 0 | $0 |
| Reid Alexander Waldman | Direktor | 27. Juli 2026 A | — | 0 | 0 | $0 |
| Christopher Nathan Martin | Direktor | 27. Juli 2026 A | — | 0 | 0 | $0 |
| Thomas Sellig | Direktor | 27. Juli 2026 A | — | 0 | 0 | $0 |
| Nancy R. Phelan | Direktor | 27. Juli 2026 A | — | 0 | 0 | $0 |
| Aaron Royston | Direktor | 27. Juli 2026 A | — | 0 | 0 | $0 |
| Richard Alistair Stewart | Direktor | 27. Juli 2026 A | 228.875 | 0 | 1 | $-378.143 |
| Jeffrey S Farrow | Direktor | 27. Juli 2026 A | — | 0 | 0 | $0 |
| Thomas Braxton King | Direktor | 4. September 2025 M | 315.142 | 0 | 1 | $-387.407 |
| Kristen B. Slaoui | Direktor | 6. Juni 2025 A | — | 0 | 0 | $0 |
| Stuart Duty | Direktor | 6. Juni 2025 A | — | 0 | 0 | $0 |
| Bridget A Martell | Direktor | 6. Juni 2025 A | — | 0 | 0 | $0 |
| Vaughn B Himes | Direktor | 22. Januar 2024 A | — | 0 | 0 | $0 |
| Donald Joseph | Direktor | 31. Mai 2022 A | — | 0 | 0 | $0 |
| Martin A Mattingly | Direktor | 31. Mai 2022 A | 10.500 | 0 | 0 | $0 |
| Jay M Moyes | Direktor | 31. Mai 2022 A | — | 0 | 0 | $0 |
| Scott Daniel Cormack | Direktor | 12. Mai 2020 A | 14.810 | 0 | 0 | $0 |
| PARKER H STEWART | Direktor | 12. Mai 2020 A | 12.500 | 0 | 0 | $0 |
| Neil James Clendeninn | Direktor | 26. Mai 2016 A | 22.421 | 0 | 0 | $0 |
| Jack Goldstein | Direktor | 26. Mai 2016 A | 17.500 | 0 | 0 | $0 |
| David V Smith | Direktor | 26. Mai 2016 A | 9.500 | 0 | 0 | $0 |
| Dwight Winstead | Direktor | 17. Mai 2010 M | 0 | 0 | 0 | $0 |
| Patrick Robert Brady | Direktor | 12. Mai 2009 A | — | 0 | 0 | $0 |
| Robert E Ivy | Direktor | 18. Mai 2007 M | 1.700 | 0 | 0 | $0 |
| George W Dunbar JR | Direktor | 10. Mai 2007 A | 3.250 | 0 | 0 | $0 |
| VENTURES WEST CAPITAL LTD | 10%-Eigentümer | 15. Dezember 2008 S | 41.763 | 0 | 0 | $0 |
| SAC CAPITAL ADVISORS LLC | 10%-Eigentümer | 19. Februar 2004 P | 1.419.752 | 0 | 0 | $0 |
| SAC CAPITAL ASSOCIATES LLC | 10%-Eigentümer | 19. Februar 2004 P | 867.376 | 0 | 0 | $0 |
| S A C CAPITAL MANAGEMENT L L C | 10%-Eigentümer | 19. Februar 2004 P | 1.419.752 | 0 | 0 | $0 |
| Steven A. Cohen | 10%-Eigentümer | 19. Februar 2004 P | 1.419.752 | 0 | 0 | $0 |
| Michael A Martino | — | 6. Juli 2010 M | 11.000 | 0 | 0 | $0 |
| Richard J Klein | — | 29. Dezember 2003 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 9 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| venBio Global Strategic Fund V, L.P., venBio Global Strategic GP V, LLC | 27. April 2026 | 9,99% | Erste Einreichung | Passive Anlage | SEC |
| TPG GP A, LLC, James G. Coulter, Jon Winkelried | 24. April 2026 | 12,60% | Erste Einreichung | — | SEC |
| Dialectic Capital Management, LP, Dialectic Partners, LLC, Dialectic Life Sciences SPV LLC, Dialectic LS Manager LLC, John Fichthorn ×3 Einreichungen | 23. März 2023 | — | Erste Einreichung | — | SEC |
| Richard Stewart | 11. August 2017 | — | Erste Einreichung | — | SEC |
| Anthony Clarke | 11. August 2017 | — | Erste Einreichung | — | SEC |
| Working Opportunity Fund (EVCC) Ltd., GrowthWorks Capital Ltd. ×5 Einreichungen | 14. Februar 2011 | — | Erste Einreichung | — | SEC |
| 28. Oktober 2010 | — | Erste Einreichung | — | SEC | |
| Abingworth LLP | 20. August 2010 | — | Erste Einreichung | — | SEC |
| SCHERING BERLIN VENTURE CORPORATION, SCHERING BERLIN INC., SCHERING INTERNATIONAL HOLDING GmbH, SCHERING AKTIENGESELLSCHAFT | 31. Oktober 2005 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 9 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,12% | 263.891 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,03% | 713.270 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 83.121 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 447.963 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,02% | 1.953.101 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 957.103 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 31.465 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.108.369 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.512 SH | 8. August 2026 | Täglich |